Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide. [electronic resource]
Producer: 19971119Description: 522-6 p. digitalISSN:- 0277-3732
- Adult
- Aged
- Analysis of Variance
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Ascites -- pathology
- Carcinoma -- drug therapy
- Cisplatin -- administration & dosage
- Confidence Intervals
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Follow-Up Studies
- Forecasting
- Humans
- Laparotomy
- Longitudinal Studies
- Middle Aged
- Multivariate Analysis
- Neoplasm Staging
- Neoplasm, Residual
- Ovarian Neoplasms -- drug therapy
- Prognosis
- Remission Induction
- Reoperation
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.